# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, Regulation 80: Amendment of regulation 71 (withdrawal of medicinal product from the market)

Extent: E+W+S+N.I.

(1) Regulation 71 is amended as follows.
(2) In paragraph (1)—
(a) for sub-paragraph (a) substitute—
“(a) under regulation 68 the licensing authority revokes or suspends a UK marketing authorisation or parallel import licence; or”; and
(b) for sub-paragraph (b) substitute—
“(b) under—
(i) regulation 69 the licensing authority suspends the use, sale, supply or offer for sale or supply within Great Britain of a product to which a UKMA(GB) relates; or
(ii) regulation 69 or Article 20(4) of Regulation (EC) No 726/2004 the licensing authority suspends the use, sale, supply or offer for sale or supply within Northern Ireland of a product to which a UKMA(NI) or UKMA(UK) relates.”.

---
Source: https://www.legislation.gov.uk/uksi/2019/775/regulation/80 (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-etc-eu-exit-regulations-2019/regulation-80
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.